Literature DB >> 392479

Aspergillus fumigatus and lung disease.

M Turner-Warwick.   

Abstract

The range of clinical presentations of lung diseases associated with Aspergillus spp. is great. The conditions are very frequently misdiagnosed but errors should be avoided if the possibility of a fungal cause is considered and simple immunological tests undertaken. Often no more than skin-prick tests and serum precipitins need to be done. In many cases, fungus is not isolated from the sputum and negative results do not exclude the possibility of A. fumigatus as the causal agent. Treatment often results in marked clinical improvement and there is evidence that suppression of recurrent episodes of bronchopulmonary aspergillosis prevents progressive lung damage.

Entities:  

Mesh:

Year:  1979        PMID: 392479      PMCID: PMC2425658          DOI: 10.1136/pgmj.55.647.642

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  Studies in chronic allergic bronchopulmonary aspergillosis. 1. Clinical and physiological findings.

Authors:  J L Malo; R Hawkins; J Pepys
Journal:  Thorax       Date:  1977-06       Impact factor: 9.139

2.  Five-year follow-up of allergic bronchopulmonary aspergillosis.

Authors:  B H Safirstein; M F D'Souza; G Simon; E H Tai; J Pepys
Journal:  Am Rev Respir Dis       Date:  1973-09

3.  Pulmonary aspergillomas treated with corticosteroids.

Authors:  D Davies; A R Somner
Journal:  Thorax       Date:  1972-03       Impact factor: 9.139

4.  Allergic broncho-pulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests.

Authors:  D S McCarthy; J Pepys
Journal:  Clin Allergy       Date:  1971-12

5.  Cytophilic antibodies in bronchopulmonary aspergilloma and cryptogenic pulmonary eosinophilia.

Authors:  E S Assem; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

  5 in total
  10 in total

1.  What happens to patients with pulmonary aspergilloma? Analysis of 23 cases.

Authors:  P Rafferty; B A Biggs; G K Crompton; I W Grant
Journal:  Thorax       Date:  1983-08       Impact factor: 9.139

2.  Influence of formic acid on fungal flora of barley and on aflatoxin production in Aspergillus flavus link.

Authors:  G Clevström; T Möller; B Göransson; A Liljensjöö; H Ljunggren
Journal:  Mycopathologia       Date:  1989-09       Impact factor: 2.574

3.  Aspergillus granuloma of the trigeminal ganglion.

Authors:  C M Wiles; R S Kocen; L Symon; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

4.  Pulmonary aspergillus infection invading the pleura.

Authors:  G Hillerdal
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

5.  Saprophytic invasion of infarcted pulmonary tissue by Aspergillus species.

Authors:  D R Buchanan; D Lamb
Journal:  Thorax       Date:  1982-09       Impact factor: 9.139

6.  Aspergillus epidural abscess in a patient with obstructive airway disease.

Authors:  Y C Chee; S C Poh
Journal:  Postgrad Med J       Date:  1983-01       Impact factor: 2.401

7.  Evaluation of PCR for detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis.

Authors:  Y Yamakami; A Hashimoto; E Yamagata; P Kamberi; R Karashima; H Nagai; M Nasu
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 8.  A case of chronic necrotizing pulmonary aspergillosis due to Aspergillus nidulans.

Authors:  M Mizuki; K Chikuba; K Tanaka
Journal:  Mycopathologia       Date:  1994-11       Impact factor: 2.574

9.  Immunosuppression in vitro by a metabolite of a human pathogenic fungus.

Authors:  A Müllbacher; R D Eichner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Molds and the lungs.

Authors:  Bharat Bhushan Sharma
Journal:  Lung India       Date:  2010-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.